Immucise Intradermal Injection System
K-Number: K181369 · 2018-11-13
Device Summary
Frequently Asked Questions
What is the Immucise Intradermal Injection System?
Immucise Intradermal Injection System is a medical device that received FDA 510(k) clearance on 2018-11-13. The listed applicant is Terumo Corporation. The 510(k) number is K181369.
When did Immucise Intradermal Injection System receive FDA 510(k) clearance?
Immucise Intradermal Injection System received FDA 510(k) clearance on 2018-11-13, under 510(k) number K181369.
Who is the listed applicant for Immucise Intradermal Injection System?
The FDA 510(k) record lists Terumo Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Immucise Intradermal Injection System?
The FDA product code for Immucise Intradermal Injection System is FMI.
Other records listing Terumo Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: FMI)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.